Portrait of Langevin, James R.

Langevin, James R.

U.S. Representative RI-2 Democratic Party

Congressional stock trade history disclosed under the STOCK Act, as filed.

Disclosed trades
414
Buys / sells
48% / 52%
Last trade
Dec 20, 2022
Last filing
Jan 9, 2023

Latest disclosed trades

Latest 10 of 414
Ticker Type Traded
GNRC Sell Dec 20, 2022
GNRC Sell Dec 12, 2022
GNRC Buy Dec 5, 2022
GNRC Buy Nov 29, 2022
META Sell Nov 14, 2022
ABNB Buy Nov 7, 2022
ABNB Sell Nov 4, 2022
DASH Sell Nov 4, 2022
DASH Sell Nov 3, 2022
SQ Buy Nov 1, 2022

Amounts are reported as STOCK Act range buckets, not exact dollar values. Trade dates are the date the politician executed the trade; filing dates are when the disclosure was filed. Sign up to filter by ticker, amount range, or filing window.

Langevin, James R. stock trade activity

FilingIQ has indexed 414 congressional stock trade disclosures for Langevin, James R.. The most recent disclosed transaction is dated Dec 20, 2022.

Across the full history, 200 purchases and 214 sales have been disclosed under the STOCK Act.

Top tickers traded by Langevin, James R.

Frequently asked

How many stock trades has Langevin, James R. disclosed?
FilingIQ tracks 414 Periodic Transaction Report disclosures for Langevin, James R., with the most recent dated Dec 20, 2022. Every entry sources back to the official House Office of the Clerk or Senate Office of Public Records.
Is Langevin, James R. a net buyer or net seller?
Across the disclosed trade history, 200 (48%) were purchases and 214 (52%) were sales. Compensation and exchanges are filtered out of these counts.
Where does FilingIQ's data on Langevin, James R. come from?
Every trade shown on this page is sourced from the STOCK Act disclosures filed with the House or Senate. FilingIQ normalizes ticker resolution, dates, and amount brackets across both chambers.

Methodology & sources

Disclosures parsed from official House Office of the Clerk and Senate Office of Public Records filings. Methodology documented on methodology. Compiled by Thomas Kraaibeek. Not investment advice; see disclaimer.